According to the Zhitong Finance App, Jiahe Bio-B (06998) announced its 2023 results, with a total revenue of zero, and 2022 revenue of about 15.9 million yuan. R&D expenses were about 564 million yuan, a year-on-year decrease of 3.36%; losses attributable to company owners were about 674 million yuan, a year-on-year decrease of 7.65%; loss per share was 1.33 yuan.

According to the announcement, the reduction in R&D expenses was mainly due to a reduction in employee welfare expenses for researchers; a reduction in research and development expenses for new drugs and clinical trials; and a reduction in raw materials and consumables used.